Clinical Trial Update: A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors [Phase 1, Phase 2]

View source ↗

Summary

A multicenter open-label Phase 1/2 trial evaluating the safety, tolerability, pharmacokinetics, and early efficacy of BAT 8010 in combination with BAT 1006 for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BAT 1006
• BAT 8010

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: RECRUITING